Page last updated: 2024-11-02

pamidronate and Myelodysplastic Syndromes

pamidronate has been researched along with Myelodysplastic Syndromes in 1 studies

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research Excerpts

ExcerptRelevanceReference
" Bone densitometry is particularly effective for early detection of patients at risk for fracture and is of practical interest since patients with osteoporosis can now be treated with Pamidronate."3.71[Bone evaluation in ten adults with cutaneous mastocytosis]. ( Armingaud, P; Benhamou, CL; Estève, E; Kerdraon, R; Lespessailles, E; Petavy-Catala, C; Zerkak, D, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armingaud, P1
Zerkak, D1
Lespessailles, E1
Petavy-Catala, C1
Kerdraon, R1
Benhamou, CL1
Estève, E1

Other Studies

1 other study available for pamidronate and Myelodysplastic Syndromes

ArticleYear
[Bone evaluation in ten adults with cutaneous mastocytosis].
    Annales de dermatologie et de venereologie, 2002, Volume: 129, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Bone Marrow

2002